Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 49

1.

Effects of blood transfusion on exercise capacity in thalassemia major patients.

Benedetto D, Rao CM, Cefalù C, Aguglia DO, Cattadori G, D'Ascola DG, Benedetto FA, Agostoni P, Sciomer S.

PLoS One. 2015 May 26;10(5):e0127553. doi: 10.1371/journal.pone.0127553. eCollection 2015.

2.

Accessory mitral valve: a rare cause of asymptomatic severe left ventricular outflow tract obstruction.

Rao CM, Lucà F, Benedetto FA, Benedetto D, Parise O, Gelsomino S.

Ann Thorac Cardiovasc Surg. 2014;20 Suppl:742-5. doi: 10.5761/atcs.cr.13-00109. Epub 2013 Nov 8.

3.

eNOS and caveolin-1 gene polymorphisms interaction and intima media thickness: a proof of concept study in ESRD patients.

Testa A, Spoto B, Sanguedolce MC, Parlongo RM, Pisano A, Tripepi G, Benedetto FA, Mallamaci F, Zoccali C.

Am J Hypertens. 2012 Jan;25(1):103-8. doi: 10.1038/ajh.2011.178. Epub 2011 Oct 6.

PMID:
21976276
4.

Neuropeptide Y receptor Y2 gene polymorphism interacts with plasma neuropeptide Y levels in predicting left ventricular hypertrophy in dialysis patients.

Testa A, Mallamaci F, Macrì R, Pisano A, Spoto B, Malatino LS, Stancanelli B, Tripepi G, Benedetto FA, Zoccali C.

J Hypertens. 2010 Aug;28(8):1745-51. doi: 10.1097/HJH.0b013e32833bd21b.

PMID:
20543711
5.

Detection of pulmonary congestion by chest ultrasound in dialysis patients.

Mallamaci F, Benedetto FA, Tripepi R, Rastelli S, Castellino P, Tripepi G, Picano E, Zoccali C.

JACC Cardiovasc Imaging. 2010 Jun;3(6):586-94. doi: 10.1016/j.jcmg.2010.02.005.

6.

Vitamin D receptor (VDR) gene polymorphism is associated with left ventricular (LV) mass and predicts left ventricular hypertrophy (LVH) progression in end-stage renal disease (ESRD) patients.

Testa A, Mallamaci F, Benedetto FA, Pisano A, Tripepi G, Malatino L, Thadhani R, Zoccali C.

J Bone Miner Res. 2010 Feb;25(2):313-9. doi: 10.1359/jbmr.090717.

7.

Soluble e-selectin is an inverse and independent predictor of left ventricular wall thickness in end-stage renal disease patients.

Stancanelli B, Malatino LS, Cataliotti A, Bellanuova I, Mallamaci F, Tripepi G, Benedetto FA, Leonardis D, Fatuzzo P, Rapisarda F, Zoccali C.

Nephron Clin Pract. 2010;114(1):c74-80. doi: 10.1159/000252806. Epub 2009 Oct 23.

PMID:
19851079
8.

Biomarkers of left atrial volume: a longitudinal study in patients with end stage renal disease.

Tripepi G, Mattace-Raso F, Mallamaci F, Benedetto FA, Witteman J, Malatino L, Zoccali C.

Hypertension. 2009 Oct;54(4):818-24. doi: 10.1161/HYPERTENSIONAHA.109.136804. Epub 2009 Jul 27.

PMID:
19635983
9.

Vascular endothelial growth factor, left ventricular dysfunction and mortality in hemodialysis patients.

Mallamaci F, Benedetto FA, Tripepi G, Cutrupi S, Pizzini P, Stancanelli B, Seminara G, Bonanno G, Rapisarda F, Fatuzzo P, Malatino LS, Zoccali C.

J Hypertens. 2008 Sep;26(9):1875-82. doi: 10.1097/HJH.0b013e328307c3d2.

PMID:
18698224
10.

Rate of atherosclerotic plaque formation predicts cardiovascular events in ESRD.

Benedetto FA, Tripepi G, Mallamaci F, Zoccali C.

J Am Soc Nephrol. 2008 Apr;19(4):757-63. doi: 10.1681/ASN.2007070813. Epub 2008 Jan 9.

11.

Urotensin II and cardiomyopathy in end-stage renal disease.

Zoccali C, Mallamaci F, Benedetto FA, Tripepi G, Pizzini P, Cutrupi S, Malatino L.

Hypertension. 2008 Feb;51(2):326-33. Epub 2007 Dec 17.

PMID:
18086953
12.

An additive effect of endothelial nitric oxide synthase gene polymorphisms contributes to the severity of atherosclerosis in patients on dialysis.

Spoto B, Benedetto FA, Testa A, Tripepi G, Mallamaci F, Maas R, Boeger RH, Zoccali C.

Am J Hypertens. 2007 Jul;20(7):758-63.

PMID:
17586410
13.

Left atrial volume monitoring and cardiovascular risk in patients with end-stage renal disease: a prospective cohort study.

Tripepi G, Benedetto FA, Mallamaci F, Tripepi R, Malatino L, Zoccali C.

J Am Soc Nephrol. 2007 Apr;18(4):1316-22. Epub 2007 Mar 14.

14.

Left atrial volume in end-stage renal disease: a prospective cohort study.

Tripepi G, Benedetto FA, Mallamaci F, Tripepi R, Malatino L, Zoccali C.

J Hypertens. 2006 Jun;24(6):1173-80.

PMID:
16685218
15.

Left ventricular systolic function monitoring in asymptomatic dialysis patients: a prospective cohort study.

Zoccali C, Benedetto FA, Tripepi G, Mallamaci F, Rapisarda F, Seminara G, Bonanno G, Malatino LS.

J Am Soc Nephrol. 2006 May;17(5):1460-5. Epub 2006 Apr 5.

16.

The E-selectin gene polymorphism and carotid atherosclerosis in end-stage renal disease.

Testa A, Benedetto FA, Spoto B, Pisano A, Tripepi G, Mallamaci F, Malatino LS, Zoccali C.

Nephrol Dial Transplant. 2006 Jul;21(7):1921-6. Epub 2006 Mar 22.

PMID:
16554320
17.

Atherosclerosis and the Glu298Asp polymorphism of the eNOS gene in white patients with end-stage renal disease.

Spoto B, Benedetto FA, Testa A, Tripepi G, Mallamaci F, Maas R, Boeger RH, Zoccali C, Parlongo RM, Pisano A.

Am J Hypertens. 2005 Dec;18(12 Pt 1):1549-55.

PMID:
16364824
18.

Cardiac consequences of hypertension in hemodialysis patients.

Zoccali C, Benedetto FA, Tripepi G, Mallamaci F.

Semin Dial. 2004 Jul-Aug;17(4):299-303. Review.

PMID:
15250922
19.

Left ventricular mass monitoring in the follow-up of dialysis patients: prognostic value of left ventricular hypertrophy progression.

Zoccali C, Benedetto FA, Mallamaci F, Tripepi G, Giacone G, Stancanelli B, Cataliotti A, Malatino LS.

Kidney Int. 2004 Apr;65(4):1492-8.

20.

Prognostic value of echocardiographic indicators of left ventricular systolic function in asymptomatic dialysis patients.

Zoccali C, Benedetto FA, Mallamaci F, Tripepi G, Giacone G, Cataliotti A, Seminara G, Stancanelli B, Malatino LS.

J Am Soc Nephrol. 2004 Apr;15(4):1029-37.

21.

Heart valve calcifications, survival, and cardiovascular risk in hemodialysis patients.

Panuccio V, Tripepi R, Tripepi G, Mallamaci F, Benedetto FA, Cataliotti A, Bellanuova I, Giacone G, Malatino LS, Zoccali C.

Am J Kidney Dis. 2004 Mar;43(3):479-84.

PMID:
14981606
22.

Prospective study of neuropeptide y as an adverse cardiovascular risk factor in end-stage renal disease.

Zoccali C, Mallamaci F, Tripepi G, Benedetto FA, Parlongo S, Cutrupi S, Iellamo D, Bonanno G, Rapisarda F, Fatuzzo P, Seminara G, Cataliotti A, Malatino LS.

J Am Soc Nephrol. 2003 Oct;14(10):2611-7.

23.

Chlamydia pneumoniae, overall and cardiovascular mortality in end-stage renal disease (ESRD).

Zoccali C, Mallamaci F, Tripepi G, Parlongo S, Cutrupi S, Benedetto FA, Bonanno G, Seminara G, Fatuzzo P, Rapisarda F, Malatino LS.

Kidney Int. 2003 Aug;64(2):579-84.

24.

Neuropeptide Y, left ventricular mass and function in patients with end stage renal disease.

Zoccali C, Mallamaci F, Tripepi G, Benedetto FA, Parlongo S, Cutrupi S, Bonanno G, Rapisarda F, Fatuzzo P, Seminara G, Cataliotti A, Malatino LS.

J Hypertens. 2003 Jul;21(7):1355-62.

PMID:
12817184
25.

Fibrinogen, inflammation and concentric left ventricular hypertrophy in chronic renal failure.

Zoccali C, Benedetto FA, Mallamaci F, Tripepi G, Cutrupi S, Parlongo S, Malatino LS, Bonanno G, Rapisarda F, Fatuzzo P, Seminara G, Nicocia G, Buemi M.

Eur J Clin Invest. 2003 Jul;33(7):561-6.

PMID:
12814392
26.

Hepatocyte growth factor and left ventricular geometry in end-stage renal disease.

Malatino LS, Cataliotti A, Benedetto FA, Stancanelli B, Bellanuova I, Belluardo P, Bonaiuto L, Tripepi G, Mallamaci F, Castellino P, Zoccali C.

Hypertension. 2003 Jan;41(1):88-92.

PMID:
12511535
27.

Diagnostic value of troponin T for alterations in left ventricular mass and function in dialysis patients.

Mallamaci F, Zoccali C, Parlongo S, Tripepi G, Benedetto FA, Cutrupi S, Bonanno G, Fatuzzo P, Rapisarda F, Seminara G, Stancanelli B, Bellanuova I, Cataliotti A, Malatino LS; Cardiovascular Risk Extended Evaluation in Dialysis Investigators.

Kidney Int. 2002 Nov;62(5):1884-90.

28.

Norepinephrine and concentric hypertrophy in patients with end-stage renal disease.

Zoccali C, Mallamaci F, Tripepi G, Parlongo S, Cutrupi S, Benedetto FA, Cataliotti A, Malatino LS; CREED investigators.

Hypertension. 2002 Jul;40(1):41-6.

PMID:
12105136
29.

Troponin is related to left ventricular mass and predicts all-cause and cardiovascular mortality in hemodialysis patients.

Mallamaci F, Zoccali C, Parlongo S, Tripepi G, Benedetto FA, Cutrupi S, Bonanno G, Fatuzzo P, Rapisarda F, Seminara G, Stancanelli B, Bellanuova I, Cataliotti A, Malatino LS.

Am J Kidney Dis. 2002 Jul;40(1):68-75.

PMID:
12087563
30.

Left ventricular hypertrophy, cardiac remodeling and asymmetric dimethylarginine (ADMA) in hemodialysis patients.

Zoccali C, Mallamaci F, Maas R, Benedetto FA, Tripepi G, Malatino LS, Cataliotti A, Bellanuova I, Böger R; CREED Investigators.

Kidney Int. 2002 Jul;62(1):339-45.

31.

Plasma norepinephrine predicts survival and incident cardiovascular events in patients with end-stage renal disease.

Zoccali C, Mallamaci F, Parlongo S, Cutrupi S, Benedetto FA, Tripepi G, Bonanno G, Rapisarda F, Fatuzzo P, Seminara G, Cataliotti A, Stancanelli B, Malatino LS.

Circulation. 2002 Mar 19;105(11):1354-9. Erratum in: Circulation 2002 May 7;105(18):2230. Cateliotti A [corrected to Cataliotti A].

PMID:
11901048
32.

Hyperhomocysteinemia predicts cardiovascular outcomes in hemodialysis patients.

Mallamaci F, Zoccali C, Tripepi G, Fermo I, Benedetto FA, Cataliotti A, Bellanuova I, Malatino LS, Soldarini A; CREED Investigators.

Kidney Int. 2002 Feb;61(2):609-14.

33.

Asymmetric dimethylarginine, C-reactive protein, and carotid intima-media thickness in end-stage renal disease.

Zoccali C, Benedetto FA, Maas R, Mallamaci F, Tripepi G, Malatino LS, Böger R; CREED Investigators.

J Am Soc Nephrol. 2002 Feb;13(2):490-6.

34.

Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease.

Zoccali C, Mallamaci F, Tripepi G, Benedetto FA, Cutrupi S, Parlongo S, Malatino LS, Bonanno G, Seminara G, Rapisarda F, Fatuzzo P, Buemi M, Nicocia G, Tanaka S, Ouchi N, Kihara S, Funahashi T, Matsuzawa Y.

J Am Soc Nephrol. 2002 Jan;13(1):134-41.

35.

Prognostic impact of the indexation of left ventricular mass in patients undergoing dialysis.

Zoccali C, Benedetto FA, Mallamaci F, Tripepi G, Giacone G, Cataliotti A, Seminara G, Stancanelli B, Malatino LS; CREED Investigators.

J Am Soc Nephrol. 2001 Dec;12(12):2768-74.

36.

Prognostic value of ultrasonographic measurement of carotid intima media thickness in dialysis patients.

Benedetto FA, Mallamaci F, Tripepi G, Zoccali C.

J Am Soc Nephrol. 2001 Nov;12(11):2458-64.

37.

Pentosidine, carotid atherosclerosis and alterations in left ventricular geometry in hemodialysis patients.

Zoccali C, Mallamaci F, Asahia K, Benedetto FA, Tripepi G, Tripepi R, Nicocia G, Buemi M, Miyata T.

J Nephrol. 2001 Jul-Aug;14(4):293-8.

PMID:
11506253
38.

Long-term CAPD patients are volume expanded and display more severe left ventricular hypertrophy than haemodialysis patients.

Enia G, Mallamaci F, Benedetto FA, Panuccio V, Parlongo S, Cutrupi S, Giacone G, Cottini E, Tripepi G, Malatino LS, Zoccali C.

Nephrol Dial Transplant. 2001 Jul;16(7):1459-64.

PMID:
11427641
39.

Cardiac natriuretic peptides are related to left ventricular mass and function and predict mortality in dialysis patients.

Zoccali C, Mallamaci F, Benedetto FA, Tripepi G, Parlongo S, Cataliotti A, Cutrupi S, Giacone G, Bellanuova I, Cottini E, Malatino LS; Creed Investigators.

J Am Soc Nephrol. 2001 Jul;12(7):1508-15.

40.

Diagnostic potential of cardiac natriuretic peptides in dialysis patients.

Mallamaci F, Zoccali C, Tripepi G, Benedetto FA, Parlongo S, Cataliotti A, Cutrupi S, Giacone G, Bellanuova I, Stancanelli B, Malatino LS; CREED Investigstors. The Cardiovascular Risk Extended Evaluation.

Kidney Int. 2001 Apr;59(4):1559-66.

41.

Left ventricular hypertrophy and nocturnal hypoxemia in hemodialysis patients.

Zoccali C, Benedetto FA, Mallamaci F, Tripepi G, Candela V, Labate C, Tassone F.

J Hypertens. 2001 Feb;19(2):287-93.

PMID:
11212972
42.

Autonomic neuropathy is linked to nocturnal hypoxaemia and to concentric hypertrophy and remodelling in dialysis patients.

Zoccali C, Mallamaci F, Tripepi G, Benedetto FA.

Nephrol Dial Transplant. 2001 Jan;16(1):70-7.

PMID:
11208996
43.

Hepatocyte growth factor predicts survival and relates to inflammation and intima media thickness in end-stage renal disease.

Malatino LS, Mallamaci F, Benedetto FA, Bellanuova I, Cataliotti A, Tripepi G, Zoccali C.

Am J Kidney Dis. 2000 Nov;36(5):945-52.

PMID:
11054350
44.

Inflammation is associated with carotid atherosclerosis in dialysis patients. Creed Investigators. Cardiovascular Risk Extended Evaluation in Dialysis Patients.

Zoccali C, Benedetto FA, Mallamaci F, Tripepi G, Fermo I, Focà A, Paroni R, Malatino LS.

J Hypertens. 2000 Sep;18(9):1207-13.

PMID:
10994751
45.

Prediction of left ventricular geometry by clinic, pre-dialysis and 24-h ambulatory BP monitoring in hemodialysis patients: CREED investigators.

Zoccali C, Mallamaci F, Tripepi G, Benedetto FA, Cottini E, Giacone G, Malatino L.

J Hypertens. 1999 Dec;17(12 Pt 1):1751-8.

PMID:
10658942
46.

Smoking, blood pressure and serum albumin are major determinants of carotid atherosclerosis in dialysis patients. CREED Investigators. Cardiovascular Risk Extended Evaluation in Dialysis patients.

Malatino LS, Benedetto FA, Mallamaci F, Tripepi G, Zoccali C, Parlongo S, Cutrupi S, Marino C, Panuccio V, Garozzo M, Candela V, Bellanuova I, Cataliotti A, Rapisarda F, Fatuzzo P, Bonanno G, Seminara G, Stancanelli B, Tassone F, Labate C.

J Nephrol. 1999 Jul-Aug;12(4):256-60.

PMID:
10493569
47.

Nocturnal hypoxemia, night-day arterial pressure changes and left ventricular geometry in dialysis patients.

Zoccali C, Benedetto FA, Tripepi G, Cambareri F, Panuccio V, Candela V, Mallamaci F, Enia G, Labate C, Tassone F.

Kidney Int. 1998 Apr;53(4):1078-84.

48.

Plasma endothelin-1 release in normal and varicose saphenous veins.

Mangiafico RA, Malatino LS, Santonocito M, Spada RS, Benedetto FA.

Angiology. 1997 Sep;48(9):769-74.

PMID:
9313626
49.

[Pseudothrombophlebitis due to an expansive popliteal cyst associated with Reiter's syndrome].

Mangiafico RA, Santonocito M, Mandalà ML, Spada RS, Benedetto FA, Malatino LS.

Minerva Med. 1995 Sep;86(9):391-4. Review. Italian.

PMID:
7501230

Supplemental Content

Loading ...
Support Center